Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Chris Peach via Flickr
Mix-up

Investigation underway after Nurofen tablet mix-up

A large number of Nurofen Plus packets were found in the UK to contain an anti-psychotic drug, Seroquel XL.

THE IRISH MEDICINE Board is investigating a case where packs of an over-the-counter painkiller were found to contain an anti-psychotic drug instead.

Pharmacies across the UK discovered they had packets of Nurofen Plus that contained blister packs of Seroquel XL 50mg.

Seroquel XL is an anti-psychotic drug used to treat conditions such as mania, bipolar depression and schizophrenia, and is prescription-only.

Nurofen Plus, however, is an over-the-counter painkiller that contains codeine.

The Irish Medicine Board is investigating the situation in Ireland, and told TheJournal.ie:

There is no evidence at present to suggest that any stocks in Ireland are affected.  The IMB is actively investigating the matter and is in communication with the concerned manufacturers as well as with the UK authorities. The IMB will continue to monitor the situation.

The Press Association reports that the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK said that the mix-up may have occurred at a wholesaler’s.

It believes that thousands of packs were affected but the three cases discovered so far were in London.

Seroquel XL and Nurofen Plus are manufactured by two different drug firms.

Your Voice
Readers Comments
7
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.